BridgeMD
New treatment option for Complex Post-Traumatic Stress Disorder
Official title Treatment of Complex Post-traumatic Stress Disorder Among Displaced People in Switzerland and Germany
ClinicalTrials.gov ID: NCT07015567
What this study is testing
- What it's testing
- In WHO ICD-11 (its latest edition), the diagnostic criteria for post-traumatic stress disorder (PTSD) were revised, and a new sibling disorder, complex post-traumatic stress disorder (CPTSD) was introduced. CPTSD is a debilitating condition associated with severe, prolonged, or chronic trauma.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 17 and older
You may be able to join if
- Informed consent signature
- Refugees and asylum seekers with a valid residence permit (N, F, B, or C status)
- Speaking Arabic, Farsi/Dari, Pashtu, Kurdish (different dialects), or Turkish
- A psychotherapy is indicated and was prescribed
- Participated to part 1 of the study and was diagnosed with CPTSD on the basis of the standard International Trauma Interview and the Socio-cultural...
You likely can't join if
- Acute psychosis
- Imminent risk of suicide
- Severe alcohol and/or substance abuse
- Being enrolled in another psychotherapy
- Inability to follow study procedures (i.e., cognitive impairment)
- Inability to give informed consent
See the full eligibility criteria
- Informed consent signature
- Refugees and asylum seekers with a valid residence permit (N, F, B, or C status)
- Speaking Arabic, Farsi/Dari, Pashtu, Kurdish (different dialects), or Turkish
- A psychotherapy is indicated and was prescribed
- Participated to part 1 of the study and was diagnosed with CPTSD on the basis of the standard International Trauma Interview and the Socio-cultural and structural addendum (SCSA). The diagnosis is done based on the...
- Acute psychosis
- Imminent risk of suicide
- Severe alcohol and/or substance abuse
- Being enrolled in another psychotherapy
- Inability to follow study procedures (i.e., cognitive impairment)
- Inability to give informed consent
- Known pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Hamburg, Free and Hanseatic City of Hamburg, Germany
- Liestal, Basel-Landschaft, Switzerland
- Aarau, Canton of Aargau, Switzerland
- Basel, Canton of Basel-City, Switzerland
- Wabern, Canton of Bern, Switzerland
- Lausanne, Canton of Vaud, Switzerland
- Yverdon-les-Bains, Canton of Vaud, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 17 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hamburg, Free and Hanseatic City of Hamburg, Germany; Liestal, Basel-Landschaft, Switzerland; Aarau, Canton of Aargau, Switzerland; Basel, Canton of Basel-City, Switzerland; Wabern, Canton of Bern, Switzerland; Lausanne, Canton of Vaud, Switzerland and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.